Atea Pharmaceuticals, Inc. (AVIR) stock
AVIRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.30+0.09 (+2.14%)
Close on Nov 13, 2026Market cap $344.88MP/E –Yield –
Atea Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Atea Pharmaceuticals's operating margin for the twelve months ending Dec 31, 2021 was 39.4%. For fiscal 2021 it was 39.4%, against -22.7% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | 39.4% | +62.1 |
| FY2020 | Dec 31, 2020 | -22.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2021 | Dec 31, 2021 | 63.1% | – |
| Q3 FY2021 | Sep 30, 2021 | -67.5% | – |
| Q2 FY2021 | Jun 30, 2021 | 14.4% | – |
| Q1 FY2021 | Mar 31, 2021 | 46.5% | – |
See a number that looks wrong?